Quantcast

Latest Mitral regurgitation Stories

2010-08-18 05:00:00

KIRKLAND, Wash., Aug. 18 /PRNewswire/ -- Cardiac Dimensions, an early stage company focused on the development of minimally invasive devices for the treatment of mitral valve disease and congestive heart failure, announced today that the 12-month follow-up results from the TITAN(TM) trial of the Company's CARILLON® Mitral Contour System will be presented at the European Society of Cardiology 2010 Congress (ESC) on August 29, 2010 in Stockholm. Professor Dr. Uta Hoppe of...

2010-05-25 06:30:00

PARIS, May 25 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced new data from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial, which provide additional details about the safety and clinical benefit of Abbott's investigational MitraClip® system for the two causes of mitral regurgitation (MR) - functional MR (FMR) or degenerative MR (DMR). In the EVEREST II trial, the 30-day major adverse event rate in the MitraClip arm was similar...

2010-05-06 13:00:00

SAN DIEGO, May 6 /PRNewswire/ -- An innovative catheter-based procedure is providing relief to patients who suffer from shortness of breath and fluid overload as the result of a severely leaky heart valve, but who are too sick for open-chest surgery, according to a study presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) 33rd Annual Scientific Sessions. Data from the Endovascular Valve Edge-to-Edge REpair STudy (EVEREST II) High Risk Registry showed...

2010-03-14 07:05:00

ATLANTA, March 14 /PRNewswire-FirstCall/ -- Late-breaking data presented today at the American College of Cardiology's 59th annual scientific session from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial demonstrated that Abbott's investigational MitraClip® system met both its primary safety and effectiveness endpoints(1), suggesting that the minimally invasive MitraClip procedure may be an important treatment option for patients with...

2010-03-14 07:00:00

EVANSTON, Ill., March 14 /PRNewswire/ -- NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman, MD, presented data today at the American College of Cardiology annual scientific sessions from the EVEREST II trial (Endovascular Valve Edge-to-Edge REpair STudy) demonstrating the MitraClip, a novel, first-in-class catheter-based device, is a safe and effective alternative to open heart surgery for select patients with mitral regurgitation. "This is a major...

2010-02-09 07:00:00

OR YEHUDA, Israel, Feb. 9 /PRNewswire/ -- Valtech Cardio Ltd. announced today that Bruce H. KenKnight, PhD has joined the Valtech team serving as President and Chief Executive Officer. This announcement comes on the heels of Valtech's recently announced Series B financing that totaled $17.8 million from new and existing investors (OXO Capital Valve Ventures, NGN Capital and Peregrine Ventures). Bruce has more than 25 years of experience in medical device research and development (R&D)...

2010-02-02 07:00:00

OR YEHUDA, Israel, Feb. 2 /PRNewswire/ -- Valtech Cardio Ltd. announced today that new and existing investors (OXO Capital Valve Ventures LLC, NGN Biomed Opportunity II, L.P., and Peregrine VC Investments II, L.P.) recently completed a Series B financing of $17.8 million. Valtech Cardio Ltd. (Valtech) is engaged in development of a portfolio of minimally-invasive surgical and transcatheter mitral valve repair and replacement technologies designed to correct or significantly improve mitral...

2009-11-02 07:00:00

ABBOTT PARK, Ill., Nov. 2 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today that it has completed its acquisition of Evalve, Inc., the global leader in the development of devices for minimally invasive repair of mitral valves. The acquisition provides Abbott with a leading presence in the growing area of non-surgical treatment for structural heart disease. Evalve's minimally invasive catheter-based MitraClip® system is the first commercially available...

2009-10-27 14:52:00

LOS ANGELES, Oct. 27 /PRNewswire/ --- Dr. Mohammad A. Gharavi and Dr. Gholam R. Mohammadzadeh are leading cardiothoracic surgeons for Mitral Valve Repair in Los Angeles. Most of us give little thought to our heart during the course of our daily life, and even less so to the small, delicately formed parts of our heart that are required to be running in top form for us to stay healthy and active. But when a doctor tells a patient that they need mitral valve repair, it can be a scary and...

2009-10-26 10:42:00

Multicenter study in 30 children and young adults shows good early outcomes BOSTON, Oct. 26 /PRNewswire-USNewswire/ -- Children born with certain heart defects have impaired blood flow from the right ventricle to the pulmonary artery leading to the lungs, requiring implanted devices (known as right-ventricular outflow tract conduits) to maintain the flow. However, these conduits fail over time, and children typically face multiple open-heart operations during their lives to reopen the...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related